Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
Acquisition positions Chiesi to expand patient access to approved treatments and advance efforts to develop new treatments for people living with rare diseases.
Bourgoin early development hub broadens offerings for oral solid dose formulations
The Award acknowledges Emcure's contribution in the field of HIV/AIDS to improve the quality of life of people living with HIV/AIDS.
China is among the top countries reporting a high number of diagnosed prevalent cases for gastric, breast, and bladder cancers among the 16 major markets
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg, (RLD Rexulti) had estimated annual sales of US $1,575 million in the US (IQVIA MAT December 2022)
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
ELL will be the preferred source of supply for some the key Raw Materials to VPPL at "Arm's Length" transaction.
Subscribe To Our Newsletter & Stay Updated
